SCHEMBL23287061

SCHEMBL23287061

COC(=O)c1ccc(N)c(NCCNc2ncc(C)s2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 4/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ GAA P10253 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC4 P56524 1/20 0.42
▸ MEF2D Q14814 1/20 0.42
▸ LNPEP Q9UIQ6 5/20 0.42
▸ ERAP2 Q6P179 2/20 0.42
▸ PTGER4 P35408 2/20 0.41
▸ LCK P06239 2/20 0.40
▸ GLA P06280 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ CASP7 P55210 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ MAPK10 P53779 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5534388 0.77 GCK (0.54) KDM4EALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL1205232 0.76 LNPEP (0.57) KDM4EALDH1A1GAAMAPTHSD17B10
SCHEMBL20266373 0.75 PTGER4 (0.64) KDM4EALDH1A1GAAMAPTHSD17B10
SCHEMBL23287058 0.74 NPC1 (0.46) KDM4EALDH1A1GAAMAPTHSD17B10
SCHEMBL23287055 0.74 LNPEP (0.53) KDM4EALDH1A1GAAMAPTHSD17B10
SCHEMBL763198 0.74 LNPEP (0.62) KDM4EALDH1A1GAAMAPTHSD17B10
SCHEMBL26971242 0.73 LNPEP (0.49) KDM4EALDH1A1GAAMAPTHSD17B10
SCHEMBL2014323 0.73 LNPEP (0.56) KDM4EALDH1A1GAAMAPTHSD17B10
SCHEMBL23703820 0.73 KDM4E (0.52) KDM4EALDH1A1GAAMAPTHSD17B10
SCHEMBL22009883 0.73 KDM4E (0.50) KDM4EALDH1A1GAAMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702404-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2023-07-18 — — US disclosed
US-11702404-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2023-07-18 — — US disclosed
CN-114630823-A GLP-1R modulating compounds 吉利德科学公司 2022-06-14 — — CN disclosed
US-20210171499-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2021-06-10 — — US disclosed
WO-2021081207-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2021-04-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702404-B2 GLP-1R modulating compounds GLP1R, GIPR, GPR119 MAPK14 2254/4885KDM4E 2322/4885ALDH1A1 3556/4885
US-20210171499-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 MAPK14 2254/4885KDM4E 2322/4885ALDH1A1 3556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback